These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 2435637

  • 1. Plasma fibronectin levels in patients with glomerular proteinuria.
    Rydzewski A, Mysliwiec M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):703-7. PubMed ID: 2435637
    [Abstract] [Full Text] [Related]

  • 2. Abnormal plasma fibronectin levels in patients with proteinuria.
    Cosio FG, Bakaletz AP.
    J Lab Clin Med; 1984 Dec; 104(6):867-72. PubMed ID: 6501999
    [Abstract] [Full Text] [Related]

  • 3. [Study of the protein C-protein S system in glomerulopathies and nephrotic syndrome].
    Rostoker G, Gouault-Heilmann M, Levent M, Lang P, Robeva R, Lagrue G.
    Nouv Rev Fr Hematol (1978); 1986 Dec; 28(6):359-63. PubMed ID: 2951650
    [Abstract] [Full Text] [Related]

  • 4. Adiponectin is increased and correlated with the degree of proteinuria, but plasma leptin is not changed in patients with chronic glomerulonephritis.
    Hayakawa K, Ohashi H, Yokoyama H, Yoshida G, Okada M, Minatoguchi S.
    Nephrology (Carlton); 2009 Apr; 14(3):327-31. PubMed ID: 19207870
    [Abstract] [Full Text] [Related]

  • 5. Plasma fibronectin and factor XIII in nephrotic syndrome.
    Rus HG, Cucuianu M, Manasia M, Spînu C, Cristea A, Nanulescu M.
    Med Interne; 1987 Apr; 25(2):105-11. PubMed ID: 3112925
    [Abstract] [Full Text] [Related]

  • 6. Proteinuria and hemoglobin levels in patients with primary glomerular disease.
    Mähr N, Neyer U, Prischl F, Kramar R, Mayer G, Kronenberg F, Lhotta K.
    Am J Kidney Dis; 2005 Sep; 46(3):424-31. PubMed ID: 16129203
    [Abstract] [Full Text] [Related]

  • 7. [alpha-Lipoprotein cholesterol content of the blood serum in nephrotic syndrome].
    Nikiforova NV, Sokolovskaia IV, Riaposova IK, Poliantseva LR.
    Ter Arkh; 1982 Sep; 54(7):57-61. PubMed ID: 7135225
    [No Abstract] [Full Text] [Related]

  • 8. Elevated plasma fibronectin levels in rats with immune and toxic glomerular diseases.
    Quiros J, Gonzalez-Cabrero J, Herrero-Beaumont G, Egido J.
    Ren Fail; 1990 Sep; 12(4):227-32. PubMed ID: 2100826
    [Abstract] [Full Text] [Related]

  • 9. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J, Bar-On H, Shafrir E.
    Isr J Med Sci; 1981 Nov; 17(11):1001-8. PubMed ID: 7319786
    [Abstract] [Full Text] [Related]

  • 10. [Fetuin A in children with nephrotic syndrome].
    Pańczyk-Tomaszewska M, Skrzypczyk P, Ziółkowska H, Adamczuk D, Roszkowska-Blaim M.
    Pol Merkur Lekarski; 2008 Nov; 24 Suppl 4():65-7. PubMed ID: 18924506
    [Abstract] [Full Text] [Related]

  • 11. Distribution of pathologic findings in individuals with nephrotic proteinuria according to serum albumin.
    Gupta K, Iskandar SS, Daeihagh P, Ratliff HL, Bleyer AJ.
    Nephrol Dial Transplant; 2008 May; 23(5):1595-9. PubMed ID: 18065791
    [Abstract] [Full Text] [Related]

  • 12. [Fibronectin and other immunologic parameters in chronic polyarthritis].
    Siegmeth W, Minar E, Graninger W, Pirich K, Zazgornik J.
    Z Rheumatol; 1984 May; 43(1):27-9. PubMed ID: 6201023
    [Abstract] [Full Text] [Related]

  • 13. Plasma viscosity as a cardiovascular risk marker in patients with proteinuria.
    Ercan M, Konukoglu D, Onen S.
    Clin Hemorheol Microcirc; 2003 May; 29(2):111-6. PubMed ID: 14610306
    [Abstract] [Full Text] [Related]

  • 14. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
    Lizakowski S, Zdrojewski Z, Jagodzinski P, Rutkowski B.
    Scand J Urol Nephrol; 2007 May; 41(3):237-42. PubMed ID: 17469034
    [Abstract] [Full Text] [Related]

  • 15. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND, Gonzales EC, Shayestehfar B, Barton CH.
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [Abstract] [Full Text] [Related]

  • 16. Blood viscosity and haemostasis in the nephrotic syndrome.
    McGinley E, Lowe GD, Boulton-Jones M, Forbes CD, Prentice CR.
    Thromb Haemost; 1983 Jun 28; 49(3):155-7. PubMed ID: 6410531
    [Abstract] [Full Text] [Related]

  • 17. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
    Tomura S, Ida T, Kuriyama R, Chida Y, Takeuchi J, Motomiya T, Yamazaki H.
    Clin Nephrol; 1982 Jan 28; 17(1):24-30. PubMed ID: 6459902
    [Abstract] [Full Text] [Related]

  • 18. High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria.
    Ariëns RA, Moia M, Rivolta E, Ponticelli C, Mannucci PM.
    Thromb Haemost; 1999 Sep 28; 82(3):1020-3. PubMed ID: 10494757
    [Abstract] [Full Text] [Related]

  • 19. Concentration of three thrombin inhibitors in the nephrotic syndrome in adults.
    Rydzewski A, Myśliwiec M, Soszka J.
    Nephron; 1986 Sep 28; 42(3):200-3. PubMed ID: 2418377
    [Abstract] [Full Text] [Related]

  • 20. Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria.
    Gansevoort RT, Heeg JE, Dikkeschei FD, de Zeeuw D, de Jong PE, Dullaart RP.
    Nephrol Dial Transplant; 1994 Sep 28; 9(3):244-50. PubMed ID: 8052429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.